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Abstract 
Background: Validation of self-reported questionnaire is very crucial in ensuring the 
quality and reliability of data collection.   
Objective: The aim of this study were i) to validate the questionnaire on tobacco 
smoke intake and second hand smoke exposure among The Malaysian Cohort (TMC) 
subjects through the determination of urinary cotinine levels, ii) to determine the 
optimal cut-off point of urine cotinine that discriminates smokers from non-smokers 
and iii) to estimate misclassification rate between self-reported smoking and urinary 
cotinine level..  
Methods: Urine samples from a total of 775 The Malaysian Cohort subjects (104 
smokers, 102 former smokers and 569 non-smokers) were obtained and urinary 
cotinine levels were determined by high-performance liquid chromatography (HPLC). 
Correlation between self-reported questionnaires and urinary cotinine were compared 
using Spearman’s correlation tests. The Receiver Operating Characteristic (ROC) 
curved was performed to define the optimal cut-off point and the diagnostic ability of 
urinary cotinine. 
Results: Urinary cotinine concentration significantly (p<0.001) correlated with 
smoking status (r=0.46), the average number of cigarettes smoked per day (r=0.53), 
duration of smoking (r=0.33) and number of cigarettes packed per year (r=0.47). 
Smokers and second hand smokers have significantly higher median cotinine levels 
(978.40 and 21.31 respectively) compared to non-smokers (15.52) and non-exposed 
(13.60) subjects. Cotinine level at cut-off value of 1.51 ng/mg creatinine is able to 
distinguish smokers and non-smokers with a sensitivity of 45.8%, specificity of 96.7%, 
84.6% positive predictive value and 81.7%. negative predictive value. The false 
positive rate and false negative rate were low with 15.4% and 18.3%, respectively. 
Conclusion: Cotinine level of 1.51 ng/mg creatinine indicated the optimal cut-off 
value to distinguish smokers and non-smokers. Self-reported smoking questionnaire 
showed significant correlation with urinary cotinine and indicated only small 
misclassification rate. Thus, the self-reported smoking questionnaire can be used to 
assess smoking exposure with careful interpretation. 
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INTRODUCTION 
 Tobacco smoking is the main cause of premature and 
preventable deaths worldwide. It is estimated that 
smoking kills 20,000 Malaysians annually and will 
increase to 30,000 by the year 2020 if the pattern of 
smoking remains the same1 . The prevalence of current 
smoker in Malaysia was 22.8% reported by The National 
Health Morbidity Survey 2015 (95%CI: 21.9, 23.8) with  
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nearly five million Malaysians aged 15 years and above 
estimated as smokers1. The smoking prevalence was 
comparable with India (24.3%) but lower than other 
neighboring countries such as Thailand (45.6%), 
Vietnam (50%), Philippines (53.8%) and China (66.9%) 
2,3.  In addition, the prevalence of exposure to second 
hand smoke (smokers and non-smokers) in Malaysia 
was 37.1% (95%CI: 35.6, 38.6). Smoking accounted for 
16.49 % of the National Health Expenditure in Malaysia 
or 0.74 % of the GDP. The burden of smoking related 
diseases; chronic obstructive pulmonary diseases, 
ischemic heart disease, and lung cancer were 67.53% of 
the total health care cost with an estimate of RM 
1,974,950,532.78 (US$ 533,770,414)4.  
 Conventionally, smoking is often assessed by 
questionnaire due to feasibility and cost effectiveness, 
however this method is prone to bias and may lead to 
underestimation of the true prevalence5,6. Recall bias and 
denial due to social stigma are the main source of self-
reporting bias especially when the subjects are under 
pressure because of social or medical disapproval, 
misunderstanding, intentional deception, 
embarrassment and shame7-10. A number of studies have 
made an effort to validate self-reported smoking, for 
example by using exhaled carbon monoxide11-13, serum, 
plasma or urine levels of nicotine14 and also urinary 
cotinine15-17. Nicotine is the primary metabolite that 
plays important role in tobacco addiction9. Thus 
cotinine, the major metabolite of nicotine, is currently 
regarded as the best biomarker to detect primary and 
second hand smokers 18. To date, biochemical 
verification on urine cotinine is globally accepted as the 
gold standard in determining smoking status due to its 
longer half-life (>20 hours), specificity to nicotine 
intake, five times higher level in the urine compared to 
other biological matrixes 19,20,21 and ability to distinguish 
smokers from non-smokers 18,22,23.  
 The questionnaire which were used for assessment of 
tobacco smoke intake and second hand smoke exposure 
was a modified version of the Global Adult Tobacco 
Survey (GATS) from the Global Tobacco Surveillance. 
This tool was design to monitor adult tobacco used and 
generate comparable data within and across countries 
systematically. In addition, it is also feasible, cost 
effective and can be used in population setting. The 
results  from the survey eventually help public health 
authority to enhance capacity to design, implement and 
evaluate tobacco control interventions24-25.  
 It is crucial to validate the TMC tobacco smoke 
intake questionnaire since the outcome can be used for 
documenting the extent of the tobacco epidemic, 
estimating population risk and smoking-attributable 
disease burden, and evaluating the progress of tobacco 
control programs26. 
 The aims of this study were; i) to assess the validity 
of self-reported TMC questionnaire on tobacco smoke 
intake and secondhand smoke exposure using urinary 
cotinine concentration, ii) to determine the optimal cut-
off point of urine cotinine that discriminates smokers 
from non-smokers and iii) to estimate misclassification 
rate between self-reported smoking and urinary cotinine 
level.   
 
MATERIALS AND METHODS 
Data sources and study samples  
 The study sample was selected from the Malaysian 
Cohort Project (TMC), a prospective population-based 
cohort including 106,527 volunteers aged between 35 
and 70 years old27. Subjects were recruited between April 
2006 and September 2012 from regions across Malaysia. 
For this cross-sectional study, a total of 775 subjects 
which comprised of 104 smokers, 102 former smokers 
and 569 non-smokers were randomly selected. Those 
who underwent nicotine replacement therapy during the 
recruitment were excluded from this study. All subjects 
gave written informed consent to participate in the study. 
 
Self-reported smoking and related status 
 Current smokers were defined as those who 
responded affirmatively to questions on: i) ever use of 
tobacco products, ii) smoked at least 100 sticks cigarettes 
in entire life, and iii) still smoking. Ex-smokers were 
those responded positively to the question (i) and (ii) and 
negative for (iii) (Supplementary data). Conversely, the 
non-smokers were defined as those who responded 
negatively to all three questions. Non-smokers were 
further divided into (i) passive smokers, who were 
exposed to second hand smoke either from family and 
workplace and (ii) non-smokers who have no exposure to 
second hand smoke. Others information related to 
smoking were also recorded such as quantity of 
cigarettes, duration of smoking, age started to smoke and 
type of tobacco used . 
 
Urinary cotinine determination 
 Urine samples were collected prior to 8 hours fasting. 
Urinary cotinine were extracted and measured by using 
the high performance liquid chromatography (HPLC) 
 
 
Figure 1: Receiver Operating Curve Characteristics 
(ROC) of the normalised cotinine level measured as 
cotinine in ng per creatinine in mg. Smokers were well 
differentiated from non-smokers; AUC: 0.89. 
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system (Agilent 1200 Series) according to the method 
described previously with slight modifications28. 
Briefly, urine samples were hydrolysed with 10 M 
sodium hydroxide, followed by liquid-liquid extraction 
with dichloromethane. The extracts were dried under 
nitrogen stream and reconstituted with 200 µl mobile 
phase comprised of 0.07M citric acid: 0.1 M sodium 
acetate: acetonitrile: methanol (10:5:3:2), pH 4.4 
adjusted by acetic acid. Cotinine was eluted isocratically 
on a LC-8-DB Supelcosil column (250 mm X 5 µm ID) 
and detected by photodiode array detector at 260 nm. 
The detection limit of this method is 5 ng/ml. The 
cotinine levels were subsequently normalized with 
urinary creatinine (Cr) and the data were reported as 
cotinine/creatinine ratio (CCR), (ng/mg Cr). The urinary 
creatinine levels were measured by using Urinary 
Creatinine Detection Kit (Arbor Assays; Luminos USA) 
with absorbance values read by using microplate reader 
(Biotek, US) at λ= 490nm. Urinary cotinine levels were 
analysed as both adjusted and unadjusted values by 
creatinine level.  
 
Statistical Analyses 
 Non-parametric test was done due to the fact that the 
distribution of the data was not normal even though data 
transformation has been applied. Differences between 
groups were compared using Kruskal Wallis and Mann-
Whitney tests.  Correlation between urine cotinine 
concentration with smoking characteristics were 
analysed using Spearman’s rank correlation.   
 The Receiver Operating Characteristic (ROC) curve 
was performed to obtain the optimal cut off to 
discriminate smokers from non-smokers as well as 
passive smokers and non-smokers. The optimal cut-off 
point commonly used Youden index (J) method29. This 
method defines the optimal cut-point as the point 
maximizing the Youden function which was the 
difference between true positive rate and false positive 
rate over all possible cut-point values. An optimal cut-
point was referred when the point classifies most of the 
individuals correctly. ROC curve mapped the sensitivity 
versus 100 − specificity for all possible values of the cut-
point between smokers and non-smokers.  
A cut-off point of cotinine level in the urine with AUC = 
100 discriminates individuals perfectly as smokers, 
while, an AUC = 50 means that there was no substantial 
difference between the level of urinary cotinine values of 
the two groups (smokers and non-smokers)29. 
 A significance threshold was set at p<0.05. All 
statistical analyses were conducted using IBM SPSS 
(Version 19).   
 
RESULTS  
 Based on the self-reported tobacco smoking 
questionnaire, a total of 104 (13.4%) smokers, 101 
(13.0%) ex-smokers and 570 (73.6%) non-smokers were 
classified based on different ethnic groups: Chinese 
(56.9%), Malay (24.9%), Indian (17.3%) and others 
(0.9%) (Table 1 and Table 2). In general, majority of the 
Table 1: Demographic data of the study (n=775) 
Characteristic N (%) 
Age (years) <40 75 (9.6) 
 41-50 303 (39.1) 
 51-60 315 (40.7) 
 >61 82 (10.6) 
Gender Male 375 (48.4) 
 Female 400 (51.6) 
Ethnic groups Malays 193 (24.9) 
 Chinese 441 (56.9) 
 Indian 134 (17.3) 
 Others 7 (0.9) 
Education 
level 
No formal 
education 37 (4.8) 
 Primary 106 (13.7) 
 Secondary 378 (48.8) 
 Tertiary 254 (32.8) 
Marital status Single 61 (7.9) 
 Married 652 (84.1) 
 Widowed 38 (4.9) 
 Divorced 24 (3.1) 
Working 
status Working 291 (37.5) 
 Not working 484 (62.5) 
Type of 
tobacco use 
Filtered kretek 
201 (25.9) 
 White cigarette 197 (25.4) 
 
Filtered white 
cigarette 
196 (25.3) 
 Kreteks 30 (3.9) 
 
Paper cigarette 
(rokok daun) 
14 (1.8) 
 
Cigar 5 (0.6) 
 Pipe 5 (0.6) 
 Cheroot 4 (0.5) 
 Bidis 3 (0.4) 
 Chewed tobacco 3 (0.4) 
   
 
Table 3:  Correlation between urinary cotinine 
concentration with self reported tobacco intake 
questionnaire 
Item 
Correlation 
coefficient  
(r) 
p 
value 
Smoking status 0.46 0.001* 
Average cigarettes  
smoked per day 
0.53 0.001* 
Age started to smoke -0.08 0.443 
Smoking duration (years) 0.33 0.001* 
Smoking history  
(packed/years) 
0.47 0.001* 
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subjects were female, married (84.1%), aged between 51 
to 60 years old (40.7%), had secondary education 
(48.8%), unemployed (62.5%) and smoking using white 
cigarette/ filtered white cigarette (50.7%) (Table 1).  
 Smokers showed significantly higher median of 
urine cotinine and CCR (urine cotinine: 978.4 ng/ml; 
CCR: 9.72 ng/mg Cr) as compared to ex-smokers (urine 
cotinine: 17.85 ng/ml; CCR: 0.22 ng/mg Cr) and non-
smokers (urine cotinine: 15.50 ng/ml; CCR: 0.29 ng/mg 
Cr). The levels of urine cotinine and CCR were 
significantly increased in smokers who reported intake 
of 11-20 cigarettes per day in comparison to less than 10 
cigarettes per day, 1328.26 ng/ml vs. 454.62 ng/ml and 
17.46 ng/mg Cr vs. 4.81 ng/mg Cr), respectively (Table 
2). Similar increment was observed in smokers with 
more than 20 cigarettes per day as compared to those 
with less than 10 cigarettes per day (urine cotinine: 
1196.65 ng/ml vs. 454.62 ng/ml and CCR: 15.06 ng/mg 
Cr vs. 4.80 ng/mg Cr). More than half of the subjects had 
started smoking at the age of 18-25 years old (58.65%) 
and this data is in agreement with the levels of urine 
cotinine and CCR measured in which the highest median 
was shown by this age group (Table 2).  
 Most of the subjects have reported previous history of 
smoking more than 20 packs of cigarettes per year 
(36.54%). However, the median of urinary cotinine and 
CCR were highest in subjects with history of smoking 11 
to 20 packs per year. Second hand smoke exposure at 
home and at workplace showed significant difference in 
urinary cotinine level compared to no exposure with the 
highest level of cotinine found in subjects who had 
reported exposure at home, followed by exposure at 
workplace. 
 In addition, we found that the creatinine-adjusted 
urinary cotinine levels were positively correlated with 
smoking status (r=0.46, p=0.001), averaged number of 
cigarettes smoked per day (r=0.53, p=0.001), smoking 
duration (r=0.33, p=0.001) and smoking history (number 
of pack per year) (r=0.47, p=0.001) as per self-reported 
questionnaires (Table 3).  
 The cut-off point for cotinine at 1.51 ng/mg Cr gave 
a good discrimination between smokers and non-smoker 
as showed by the Receiver Operating Characteristic 
(ROC) curve with area under the curve, AUC = 0.89 
(Figure 2). Majority of the smokers had urinary cotinine 
level more than 1.51 ng/mg Cr (84.6%), while 81.7% 
non-smokers and 84.3% ex-smokers had urinary cotinine 
Table 2: Urinary cotinine and cotinine/creatinine ratio (CCR) levels by smoking characteristics. 
Smoking characteristics n % 
Cotinine concentration 
(ng/ml) 
CCR (ng/mg 
Creatinine) 
Median±(IQR) Median±(IQR) 
Smoking status     
Smoker 104 13.42 978.4(1612.75) 9.72±(20.12) 
Ex-Smoker 101 13.03 17.85(54.16)a 0.22±(0.82)a 
Non-smoker 570 73.55 15.50(34.25)a 0.29±(0.84)a 
                        Smokers    
              Averaged number of 
          cigarette smoked per day    
<10 52 50.01 454.62 (1021.98) 4.80 (15.35) 
11 to 20 42 40.38 1328.26 (1398.66)b 17.46 (30.04)b 
>20 10 9.61 1196.65 (1349.28)b 15.06 (42.06)b 
Age started smoking     
< 17 27 25.96 876.17 (1094.87) 10.31 (19.19) 
18 - 25 61 58.65 1160.28 (1793.56) 14.15 (32.73) 
> 25 16 15.38 609.87 (1110.35) 6.19 (10.42) 
Tobacco smoking history (pack-years)     
<10 34 32.69 278.62 (685.81) 2.69 (7.18) 
11 to 20 29 27.88 1160.28 (1730.60)c 17.35 (37.81)c 
>20 38 36.54 1350.41 (1317.56)c 15.37 (30.98)c 
Non-smokers     
No second hand smoke exposure at 
home and workplace 
264 46.4 13.60(30.36) 0.28(0.79) 
Second hand smoke exposure at home 96 16.87 21.31(62.47)d 0.44(1.41) 
Second hand smoke exposure at 
workplace 
143 25.13 15.19(47.76)d 0.28(1.02) 
a p<0.05 as compared to smokers   
b p<0.05 as compared to number of cigarette smoked per day <10   
c p<0.05 as compared to tobacco smoking history (pack-years) <10   
d p<0.05 as compared to no second hand smoke exposure at home and workplace   
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level less than 1.51 ng/mg Cr (Table 4).  The cut-off 
value also gave a good diagnostic accuracy results with 
sensitivity of 42.3%, 96.7% specificity, 84.6% positive 
predictive value and 81.7% negative predictive value. 
The false positive rate and false negative rate were low 
with 15.4% and 18.3%, respectively (Table 5). The 
prevalence of smoking was lower based on self- reported 
questionnaire (13.42%) as compared to prevalence using 
cotinine levels above 1.51 ng/mg Cr (26.84%).  
 
DISCUSSION 
 Based on the self-reported data, the prevalence of 
smoking from this study was 13.42% which was lower 
than the recent prevalence data from the Malaysia 
National Health and Morbidity Survey (22.8%)1. 
However, based on the laboratory results obtained in this 
current study, prevalence value was slightly higher 
(26.84%) and closed to the value reported by the 
Malaysia National Health and Morbidity Survey. The 
discrepancy of the prevalence might be due to the under-
reporting of the result. This is consistent with previous 
study that also found underestimation of self-reported 
smoking while cotinine was considered as more accurate 
biomarker of smoke exposure30. In this study, we found 
smokers have significantly higher levels of urinary 
cotinine as compared to ex-smokers and non-smokers. 
There was a relationship between urinary cotinine and 
smoking among the smokers with the higher number of 
cigarettes smoked per day correlated with higher levels 
of the measured urinary cotinine. In addition, the 
questionnaire items which were smoking status, 
averaged number of cigarettes smoked per day, smoking 
duration and number of cigarettes packed per year 
indicated significantly moderate correlation (0.33-0.47) 
with urine cotinine. These results were consistent with 
other findings conducted in a similar population14. The 
results showed that, although self-reporting 
questionnaires typically underestimate the smoking rate, 
such outcomes are still highly consistent with those 
determined through a urinary test. Thus, self-reporting 
questionnaires can serve as an effective tool for assessing 
smoking behaviour. Taken together, these results 
indicated that our questionnaires are consistent in 
capturing smoking and secondhand smoker status.  
 To date, there is no standardised urinary cotinine cut-
off value for differentiating smokers from non-smoker. It 
remains arbitrary due to the overlap between non-
smokers who are highly exposed to second hand smoke 
and occasional smokers or those who inhale very little 
smoke. Our study indicate that the cotinine cut-off value 
of 1.51 ng/mg Cr was an optimal value to distinguish the 
smoking status with an acceptable sensitivity and 
specificity in the Malaysian population. However, our 
proposed cut-off value was higher than the value reported 
from a population study among young Malaysian adults 
in 200914. It is important to note that our data used 
adjusted creatinine-corrected cotinine level for 
differences in urinary excretion volume whereas the latter 
was without creatinine normalization. Moreover, the 
difference in population age may contribute to the 
discrepancy, as younger adult smokers are likely in the 
process of becoming established smokers. 
 Nonetheless, the disparity of the cut-off value is very 
much dependent on the concentration of the urinary 
Table 4: Contingency table of Cotinine concentration at cut off value of 1.51 ng/mg creatinine 
 Number of subjects, n (%) 
Smoking 
status 
Cotinine concentration >1.51 ng/mg 
creatinine 
Cotinine concentration ≤1.51 ng/mg 
creatinine 
Total 
Smokers 88 (84.6)  16 (15.4) 104 
Ex-smokers 16 (15.7) 86 (84.3)  102 
Non-smokers 104 (18.3) 465 (81.7) 569 
Total 208 (26.84) 567 (73.16) 775 
 
Table 5: Diagnostic parameters of cotinine concentration. 
 
  Cotinine concentration 
Self-reported smoking  Smoking 
status 
Smokers Non-smokers   
Smokers 88 (TP) 16 (FP) PPV: 0.85 
Non-smokers 104 (FN) 465 (TN) NPV: 0.82 
 
  Sensitivity: 0.46 Specificity: 0.97 
TP: True Positive, FP: False Positive, FN: False Negative, TN: True Negative, PPV: Positive Predictive Value, 
NPV: Negative Predictive Value 
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cotinine. The concentration of urinary cotinine are 
reliant on individual variability such as the duration and 
the intensity of exposure or smoking, the pattern of 
smoking and nicotine uptake, metabolism and 
elimination rate 31-33. Furthermore, the cut-off points of 
urinary cotinine may also be influenced by ethnic 
specificity due to racial differences in nicotine 
pharmacokinetics and genetic polymorphisms10-34. 
 The range of misclassification between self-reported 
non-smokers and ex-smokers obtained in this study 
using the optimal urinary cotinine cut-off value of 1.51 
ng/mg Cr was in accordance with another study 
conducted in the Aboriginal population35.However, 
some studies reported a wider range, between 6.4% to 
57.1% in Aboriginal and Indian populations36,37. In spite 
of this, the comparison of smoking misclassification 
across studies needs to be interpreted cautiously as each 
study is different in terms of design and methodology 
such as the cut off points to distinguish smokers from 
non-smokers, the use of creatinine normalization, study 
settings (clinical settings compared with community 
based studies), denominators used for misclassification 
rates (smokers compared with non-smokers), analytical 
techniques (gas chromatography compared with 
radioimmunoassay),  racial differences in nicotine 
metabolism, education level, past smoking history and 
smoking habits (smoking behaviours that may affect 
nicotine intake)9,10,34. In this study, measurement of 
cotinine level was performed by using HPLC tool, which 
provides superior sensitivity and specificity as compared 
to other biochemical techniques used in cotinine 
quantitation such as enzyme-linked immunosorbent 
assay38 and colorimetric-based autoanalyser assay39, but 
more cost effective as compared to higher end mass 
spectrometry40 and radioimmunoassay41. The positive 
correlation between the measured creatinine-adjusted 
urinary cotinine and smoking status demonstrates the 
reliability of this practical yet economical approach for 
evaluating exposure to smoking, especially in 
laboratories not equipped with high-end mass 
spectrometry system. 
 The grey zone still exists between occasional 
smokers and non-smokers exposed to second hand 
smoke, where differentiation is deemed challenging. 
This is further supported by the fact that the serum 
cotinine level in these occasional smokers decreased 
rapidly in a short period of time as compared to their 
‘heavier’ counterparts10. Nevertheless, the use of a 
biological marker such as cotinine as applied in this 
study to validate self-reported data on smoking is 
relevant as recall bias and social stigma have been 
implicating the accuracy of the self-reported data in the 
form of questionnaire where under-reporting of the true 
smoking event was consistently observed10. Apart from 
its applicability for validating self-reported smoking 
data, this urinary cotinine assessment can be 
incorporated as additional assessment on high-risk 
population who is exposed to second-hand smoke 
towards smoking-related diseases. Nonetheless, more 
studies are needed to link those diseases to cotinine 
levels with careful interpretation particularly in relation 
to the cut-off points prior to its clinical application. 
 
CONCLUSION 
 Cotinine level of 1.51 ng/mg creatinine indicated the 
optimal cut-off value to distinguish smokers and non-
smokers. Self-reported smoking questionnaire showed 
significant correlation with urinary cotinine and indicated 
only small misclassification rate. Thus, the self-reported 
smoking questionnaire can be used to assess smoking 
exposure with careful interpretation.  
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